Friday, August 21, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
HEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice OverpaymenttodayHEALTHCARE & FDACMS Freezes $1 Billion in Medicaid Payments to California and Minnesota — Managed Care Insurers Face Revenue Gaps4 weeks agoENERGYNewsom Passes Diablo Canyon Decision to SuccessoryesterdayWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Defense Supply Chain — and Sends Money to U.S. Miners4 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervalued2 days agoENERGYTrump's Saudi Nuclear Pact Without Enrichment Safeguards Heads to Congress — U.S. Uranium and Nuclear Services Names Are the Play4 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers Win2 days agoCRYPTOWhite House Concedes Ethics Provision in Crypto Bill — Clearing the Last Roadblock for Stablecoin Legislation4 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnostics3 days agoTECHBosch's $225M CHIPS Act Award for Roseville Chips Away at U.S. Dependence on Asian Auto Semiconductors4 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopoly3 days agoTRADE & TARIFFSTrump's 50% Canada Tariff Threat Keeps U.S. Aluminum Tight — Domestic Producers Win, Manufacturers Pay4 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfall3 days agoDEFENSEHouse Passes $1.15T Defense Bill — Missile Defense, Shipbuilding, and Next-Gen Air Get the Money4 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Eases3 days agoENERGYNRC Approves Holtec's Upgraded Spent Fuel Storage System — A Quiet Win for Nuclear's Capacity Expansion4 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demand4 days agoWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Military Supply Chain — These Miners Fill the Gap4 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressure4 days agoDEFENSEOracle Lands a $7B Pentagon Software Contract — and the Market Should Take It Seriously4 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boost4 days agoENERGYTrump Signs the Saudi Nuclear Deal — and U.S. Uranium and Reactor Companies Are the Quiet Winners4 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Path5 days agoDEFENSEThe U.S.-Iran War Is Costing $37.5B and Counting — Here's Where That Money Goes4 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings5 days agoCRYPTOThe Senate's Landmark Crypto Bill Creates Winners Inside the ETF and Exchange Stack4 weeks agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persists6 days agoTRADE & TARIFFSTariffs on Indian Pharma Are Coming — and U.S. Generic Drug Buyers Will Pay the Bill4 weeks agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refund6 days agoHEALTHCARE & FDACMS's Star Ratings Overhaul Rescues the Biggest Medicare Advantage Insurers — For Now4 weeks agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makers6 days agoMARKETSChina's $765M Antitrust Fine on Trip.com Is a Warning Shot for U.S.-Listed Chinese Consumer Stocks4 weeks agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Winslast weekDEFENSEPentagon's $7B Oracle Software Deal Is One of the Cleanest Defense-Tech Wins in Years4 weeks agoDEFENSEBlackSky Lands Multi-Year Satellite Contractlast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Direct Win for Oracle, Pressure on Smaller Defense IT Rivals4 weeks agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibilitylast weekTECHFCC Tightens Submarine Cable Licensing Rules—Tech Giants Face New Compliance Costs, Telecom Carriers Gain Regulatory Clarity4 weeks agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contractlast weekHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—UnitedHealth, Humana, and Anthem Positioned to Gain from Simplified Metrics4 weeks agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestocklast weekDEFENSEHouse Passes $1.15 Trillion Defense Bill—Lockheed, Raytheon, and General Dynamics Positioned for Record Spending4 weeks agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Casklast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Largest Defense IT Overhaul in Years3 weeks agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidancelast weekDEFENSERocket Lab Wins $266M Space Force Contract—Suborbital Launch Capability Becomes Defense Asset3 weeks agoWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacinglast weekHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—Big Insurers Win, Quality Metrics Tighten3 weeks agoWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shiftlast weekDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation3 weeks agoDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gainslast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue3 weeks agoWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertaintylast weekCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity3 weeks agoTECHTrump Administration Adds 6 Chipmakers to U.S. Portfoliolast weekHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem3 weeks agoDEFENSEPentagon Awards Space-Based Target Tracking Contractslast weekDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue3 weeks agoENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakeslast weekDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue3 weeks agoWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employerslast weekMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue3 weeks agoTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backinglast weekENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors3 weeks agoTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payoutlast weekSEARCH DEMANDCasgevy List Price: $2.2 Million3 weeks agoHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma2 weeks agoSEARCH DEMANDData Center Power Exchange3 weeks agoHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices2 weeks agoTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall3 weeks agoMARKETSFTC Threatens Booking Holdings Over Priceline Practices2 weeks agoTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing3 weeks agoDEFENSERising Defense Spending Lifts Northrop Grumman Outlook2 weeks agoHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win3 weeks agoTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone2 weeks agoDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue3 weeks agoHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief2 weeks agoWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market3 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure2 weeks agoHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption3 weeks agoHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win2 weeks agoENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk2 weeks agoTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze2 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare & FDA

Medicare Starts Covering GLP-1 Obesity Drugs — Novo Nordisk and Eli Lilly Are the Direct Winners

For the first time, Medicare will reimburse weight-loss drugs, opening a market of millions of seniors who couldn't previously afford Ozempic or Zepbound.

Image: Money Racket
By at Money Racket · Jul 7, 2026
1-YEAR MOVE
+45% −37%
NVO ▼14.3% LLY ▲43.0% UNH ▲20.3%
1-year price move by ticker
TickerCompany1-year change
NVONovo Nordisk−14.3%
LLYEli Lilly+43.0%
UNHUnitedHealth+20.3%

Medicare has launched coverage for GLP-1 receptor agonists for obesity treatment, a historic policy shift that for the first time makes drugs like semaglutide and tirzepatide available to Medicare beneficiaries who qualify. The program is being described as a "bridge" with specific eligibility criteria, meaning not every obese Medicare patient automatically qualifies — but the coverage door is now open.

Medicare's 65 million members are now a potential customer base for Novo and Lilly — the question is how fast CMS lets them in the door.

Who cashes in: Novo Nordisk NVO makes Ozempic and Wegovy (semaglutide) and is the most direct beneficiary — Medicare's senior population skews toward exactly the cardiovascular-risk profile that semaglutide's label covers. One analyst has estimated NVO may be 48% undervalued on this catalyst alone. Eli Lilly LLY makes Zepbound and Mounjaro (tirzepatide), which has shown superior weight-loss efficacy in trials; it competes directly for the same Medicare patients. Both are large-cap names where the stock may already price in some of this, but the volume upside from Medicare's 65-million-member pool is genuinely large. Pharmacy benefit managers — CVS Health CVS via Caremark and Cigna CI via Express Scripts — will process the claims and could see revenue growth, though their margins on specialty drugs are thin.

Who's exposed: UnitedHealth UNH and other Medicare Advantage insurers face the most direct cost pressure. If GLP-1 utilization among seniors ramps faster than CMS adjusts benchmark rates, MA plans absorb the margin hit. KFF data already shows Medicare Advantage bonus payments exceeding $13 billion this year, suggesting the system is under financial stress before GLP-1 costs fully land.

What to watch next: CMS's final eligibility criteria and whether Medicare Advantage plans are required to cover GLP-1s at the same terms as traditional Medicare. The gap between "coverage exists" and "coverage is accessible" will determine how fast volume actually builds.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/medicare-glp1-coverage-novo-lilly-windfall/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →